Asian Paints:2,685.50+10.70 (+0.40%)
Cipla:1,411.20-18.30 (-1.28%)
Eicher Motors:7,512.00+93.47 (+1.26%)
Nestle India:1,420.00-3.56 (-0.25%)
Grasim Inds:3,082.70+9.83 (+0.32%)
Hindalco Inds.:950.00-9.31 (-0.97%)
Hind. Unilever:2,132.60+34.20 (+1.63%)
ITC:279.95+0.59 (+0.21%)
Trent:2,856.40-3.72 (-0.13%)
Larsen & Toubro:3,808.30+32.85 (+0.87%)
M & M:3,155.00+37.10 (+1.19%)
Reliance Industries:1,321.00+24.38 (+1.88%)
Tata Consumer:1,078.30-10.23 (-0.94%)
Tata Motors PVeh:333.40+1.59 (+0.48%)
Tata Steel:184.55-0.95 (-0.51%)
Wipro:175.83-1.90 (-1.07%)
Apollo Hospitals:8,805.00-82.66 (-0.93%)
Dr Reddy's Labs:1,206.20-18.24 (-1.49%)
Titan Company:4,643.80+18.04 (+0.39%)
SBI:1,040.60+9.38 (+0.91%)
Shriram Finance:1,029.70+5.33 (+0.52%)
Bharat Electron:408.80+1.71 (+0.42%)
Kotak Mah. Bank:386.90+9.77 (+2.59%)
Infosys:1,102.20+19.81 (+1.83%)
Bajaj Finance:1,052.30+14.73 (+1.42%)
Adani Enterp.:3,159.50+8.19 (+0.26%)
Sun Pharma.Inds.:1,942.10-8.00 (-0.41%)
JSW Steel:1,231.90+10.87 (+0.89%)
HDFC Bank:819.15+10.83 (+1.34%)
TCS:2,260.90+59.87 (+2.72%)
ICICI Bank:1,439.50+21.27 (+1.50%)
Power Grid Corpn:283.30+2.55 (+0.91%)
Maruti Suzuki:13,770.00-12.40 (-0.09%)
Axis Bank:1,321.20+13.60 (+1.04%)
HCL Technologies:1,208.80+21.37 (+1.80%)
O N G C:246.88+0.12 (+0.05%)
NTPC:341.80-0.65 (-0.19%)
Coal India:426.55-0.81 (-0.19%)
Bharti Airtel:1,907.30-14.41 (-0.75%)
Tech Mahindra:1,556.70+46.37 (+3.07%)
Jio Financial:243.89+8.25 (+3.50%)
Adani Ports:1,835.10+8.77 (+0.48%)
HDFC Life Insur.:570.65+3.06 (+0.54%)
SBI Life Insuran:1,826.50+4.37 (+0.24%)
Max Healthcare:1,085.80-12.41 (-1.13%)
UltraTech Cem.:11,735.00-36.49 (-0.31%)
Bajaj Auto:10,408.00+76.45 (+0.74%)
Bajaj Finserv:1,855.70+17.10 (+0.93%)
Interglobe Aviat:5,270.50+4.74 (+0.09%)
Eternal:286.60+0.14 (+0.05%)
Asian Paints:2,685.50+10.70 (+0.40%)
Cipla:1,411.20-18.30 (-1.28%)
Eicher Motors:7,512.00+93.47 (+1.26%)
Nestle India:1,420.00-3.56 (-0.25%)
Grasim Inds:3,082.70+9.83 (+0.32%)
Hindalco Inds.:950.00-9.31 (-0.97%)
Hind. Unilever:2,132.60+34.20 (+1.63%)
ITC:279.95+0.59 (+0.21%)
Trent:2,856.40-3.72 (-0.13%)
Larsen & Toubro:3,808.30+32.85 (+0.87%)
M & M:3,155.00+37.10 (+1.19%)
Reliance Industries:1,321.00+24.38 (+1.88%)
Tata Consumer:1,078.30-10.23 (-0.94%)
Tata Motors PVeh:333.40+1.59 (+0.48%)
Tata Steel:184.55-0.95 (-0.51%)
Wipro:175.83-1.90 (-1.07%)
Apollo Hospitals:8,805.00-82.66 (-0.93%)
Dr Reddy's Labs:1,206.20-18.24 (-1.49%)
Titan Company:4,643.80+18.04 (+0.39%)
SBI:1,040.60+9.38 (+0.91%)
Shriram Finance:1,029.70+5.33 (+0.52%)
Bharat Electron:408.80+1.71 (+0.42%)
Kotak Mah. Bank:386.90+9.77 (+2.59%)
Infosys:1,102.20+19.81 (+1.83%)
Bajaj Finance:1,052.30+14.73 (+1.42%)
Adani Enterp.:3,159.50+8.19 (+0.26%)
Sun Pharma.Inds.:1,942.10-8.00 (-0.41%)
JSW Steel:1,231.90+10.87 (+0.89%)
HDFC Bank:819.15+10.83 (+1.34%)
TCS:2,260.90+59.87 (+2.72%)
ICICI Bank:1,439.50+21.27 (+1.50%)
Power Grid Corpn:283.30+2.55 (+0.91%)
Maruti Suzuki:13,770.00-12.40 (-0.09%)
Axis Bank:1,321.20+13.60 (+1.04%)
HCL Technologies:1,208.80+21.37 (+1.80%)
O N G C:246.88+0.12 (+0.05%)
NTPC:341.80-0.65 (-0.19%)
Coal India:426.55-0.81 (-0.19%)
Bharti Airtel:1,907.30-14.41 (-0.75%)
Tech Mahindra:1,556.70+46.37 (+3.07%)
Jio Financial:243.89+8.25 (+3.50%)
Adani Ports:1,835.10+8.77 (+0.48%)
HDFC Life Insur.:570.65+3.06 (+0.54%)
SBI Life Insuran:1,826.50+4.37 (+0.24%)
Max Healthcare:1,085.80-12.41 (-1.13%)
UltraTech Cem.:11,735.00-36.49 (-0.31%)
Bajaj Auto:10,408.00+76.45 (+0.74%)
Bajaj Finserv:1,855.70+17.10 (+0.93%)
Interglobe Aviat:5,270.50+4.74 (+0.09%)
Eternal:286.60+0.14 (+0.05%)
Arihant Plus App

Arihant Plus App

Emcure Pharmaceuticals Ltd

Emcure Pharma | 544210

Market Closed
1,763.90
38.76 (-2.15%)
As on 17/07/26, 1:04 PM
Market Cap34,193.64 CR
Current Price₹1,763.9
High / Low₹1,944 / 1,260
PE Ratio29.83
Book Value₹234.65
Dividend Yield0.28%
ROCE20.01%
ROE12.79%
Face Value₹2.00
Current Vol.53,949
Average Vol.---
ISININE168P01015
PB Ratio4.57
Debt to Equity0.45
Net Profit Margin8.96
Operating Margin19.39

Share Price Chart - Emcure Pharmaceuticals Ltd

+0.00 (+0.00%)6M

Stock Performance

1,802.71,802.7
1,763.9
Previous CloseToday's Open
1,2601,944
1,763.9
52W Low52W High
₹1,802.7Today's Open
₹1,802.7Previous Close
53,949Volume
₹1,26052W Low
₹1,94452W High

Ratios

No data available

About Company

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001
  • Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad
  • range of pharmaceutical products across several major therapeutic areas
  • In India, they are present across acute and chronic therapeutic areas, and their key therapeutic areas include gynecology, cardiovascular, vitamins, minerals and nutrients, human immunodeficiency virus antivirals, blood-related and oncology/anti-neoplastics
  • The Company has 13 manufacturing facilities across India
  • It keeps a strong track record in developing portfolios of differentiated products, including chiral molecules, complex APIs, biologics and novel drug delivery systems
  • It has a portfolio of 11 chiral molecules, of which 6 have been launched so far
  • In year 1999, Lasor Drugs Limited was amalgamated with the Company
  • Thereafter, Emcure Laboratories Private Limited

Ethics: Emcure Pharmaceuticals Ltd is flagged for

paw image

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI52.13
SMA 201818.86
SMA 501751.29
SMA 1001650.65
SMA 2001532.97
SMA 101814.72
MACD_12_26_Days15.75
EMA10Day1809.16
EMA20Day1802.30
EMA50Day1752.57
MACD_12_26_9_Days-8.80
EMA100Day1676.07
EMA200Day1576.29

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth18.59%
ROE19.12%
EBITDA Margin19.39%

All figures in ₹ Crores

Indicators20252024202320222021
Revenue
7,896.00
6,658.25
5,985.81
5,855.39
5,033.47
Interest
175.78
237.15
213.61
175.98
154.94
Expenses
6,427.14
5,428.53
4,804.63
4,525.48
3,817.19
Financing Profit
1,541.64
1,286.71
1,227.09
1,393.38
1,250.16
Financing Margin %
20%
19%
20%
24%
25%
Other Income
72.79
56.99
45.91
63.47
33.88
Depreciation
384.13
312.41
260.12
244.86
249.99
Profit before tax
971.35
727.23
747.22
972.55
840.70
Tax %
27%
27%
25%
28%
28%
Net Profit
707.47
527.57
561.85
702.56
607.25
EPS in Rs
36.43
27.54
29.42
36.62
21.68
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

DealDateTypeQuantityPriceTraded %
AXIS MUTUAL FUND25 Jun ‘26Purchase1,37,5901,81714.92%
GOLDMAN SACHS INVESTMENTS MAURITIUS I LIMITED25 Jun ‘26Purchase1,37,5901,81714.92%
HDFC STANDARD LIFE INSURNACE25 Jun ‘26Purchase1,57,9491,81717.12%
HSBC MUTUAL FUND25 Jun ‘26Purchase1,37,5901,81714.92%
MORGAN STANLEY ASIA SINGAPORE PTE25 Jun ‘26Purchase1,37,5901,81714.92%
ADITYA BIRLA SUN LIFE MUTUAL FUND25 Jun ‘26Purchase2,61,4201,81728.34%
HDFC STANDARD LIFE INSURANCE COMPANY LTD25 Jun ‘26Purchase5,56,9541,81760.38%
BNP PARIBAS FINANCIAL MARKETS25 Jun ‘26Purchase1,37,5921,81714.92%
ALPHA ALTERNATIVES EQUITY ABSOLUTE RETURN FUND25 Jun ‘26Purchase1,37,5931,81714.92%
AXIS MUTUAL FUND25 Jun ‘26Purchase1,37,5911,81714.92%

News

16 Jul 2026 12:00 am

Emcure Pharmaceuticals to hold board meeting

Emcure Pharmaceuticals to hold board meeting

11 Jul 2026 12:00 am

Gennova Biopharmaceuticals to transfer its mRNA business to Immunoscript Life Science

Gennova Biopharmaceuticals to transfer its mRNA business to Immunoscript Life Science

11 Jul 2026 12:00 am

Emcure Pharma divests mRNA business for Rs 139.5 crore to Immunoscript Life Science

Emcure Pharma divests mRNA business for Rs 139.5 crore to Immunoscript Life Science

Record Date
Corporate Action
Information
Announcement Day
28 Aug 2025
AGM
AGM
01 Aug 2025
14 Aug 2025
Final Dividend (₹3)
Board of Directors of the Company at its meeting held today i.e. Thursday, May 22, 2025, has inter-alia transacted and approved/ recommended the following businesses: Recommended a final dividend of Rs. 3 / - (Rupees Three only) per equity share of Rs. 10 /- (Rupees Ten only) each of the Company (at the rate of 30%) for the financial year ended March 31, 2025, subject to approval of the Members of the Company at the ensuing Annual General Meeting of the Company. Dividend, once approved by the Members, shall be paid within the prescribed timeline under the Companies Act, 2013. Intimation of the 44th AGM and Record date for Final Dividend for the financial year ended March 31, 2025. (As Per BSE Announcement Dated on: 01/08/2025)
22 May 2025

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
1,803
34,201
36
7
25
0
8.96%
1,950
4,67,870
38
6
30
0
19.78%
7,320
1,94,316
74
12
63
0
23.41%
5,003
1,69,316
77
20
51
1
11.09%
1,429
1,15,477
30
3
23
0
9.92%
1,154
1,15,062
21
4
17
0
9.82%
2,500
1,14,310
20
5
16
0
19.16%
2,545
1,05,107
52
6
36
0
13.57%
1,224
1,02,156
25
3
17
0
12.34%
1,548
89,914
25
2
17
0
10.98%
Showing 10 of 133 Results

Frequently Asked Questions

What is Share Price of Emcure Pharmaceuticals Ltd?

The current share price of Emcure Pharmaceuticals Ltd (Emcure Pharma) is ₹1763.90. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Emcure Pharmaceuticals Ltd?

The Price-to-Earnings (P/E) ratio of Emcure Pharmaceuticals Ltd is 1763.90. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Emcure Pharmaceuticals Ltd?

Emcure Pharmaceuticals Ltd has a 52-week high of ₹1944.00 and a 52-week low of ₹1260.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Emcure Pharmaceuticals Ltd?

Emcure Pharmaceuticals Ltd offers a dividend yield of 0.20%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Emcure Pharmaceuticals Ltd?

The Earnings Per Share (EPS) of Emcure Pharmaceuticals Ltd is ₹49.88. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Emcure Pharmaceuticals Ltd?

Emcure Pharmaceuticals Ltd has a Return on Equity (ROE) of 12.79%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2